Adenovirus
Research from University of Pittsburgh, Pittsburgh Cancer Institute reveals new findings on adenovirus
Published in Medical Verdicts and Law Weekly, May 15th, 2008
New investigation results, 'Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma,' are detailed in a study published in Journal of Immunotherapy. According to a study from the United States, "We performed a phase 1/2 trial testing the safety, toxicity, and immune response of a vaccine consisting of autologous dendritic cells (DCs) transduced with a replication-defective adenovirus (AdV) encoding the full-length melanoma antigen MART-1/Melan-A (MART-1). This vaccine was designed to activate MART-1-specific CD+8 and CD4+ T cells."
"Metastatic melanoma patients received 3 injections of 106 or 10(7) DCs, delivered...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Fibrosis
Research from McGuireWoods LLP provide new insights into fibrosis - Acid Reflux Disease Epidemiology
Researchers from Veterans Affairs Medical Center detail findings in acid reflux disease epidemiology - Acne Vulgaris Therapy
Data on acne vulgaris therapy discussed by P. Andres and colleagues - Acne Vulgaris Therapy
Findings from Center For Clinical Research advance knowledge in acne vulgaris therapy - Acute Myeloid Leukemia
Research reports on acute myeloid leukemia from Medical University of Silesia provide new insights - Adverse Drug Reactions
New adverse drug reactions data have been reported by researchers at Stanford University - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
